The U.S. Food and Drug Administration granted Breakthrough Therapy designation to BPL-003, a nasal spray treatment for treatment-resistant depression being ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE